RedHill Biopharma Announces Confirmatory Phase III Study Initiated with RHB-105 (TALICIA™) for H. pylori Infection Jun 15, 2017 Life Science
ACEA Biosciences Announces Successful Completion of Phase I Clinical Study of Novel Autoimmune Disease Drug Jun 14, 2017 Life Science
RedHill Biopharma Initiates Promotion of Donnatal® and EnteraGam® in the U.S Jun 14, 2017 Life Science
RedHill Biopharma Announces Successful Phase III Top-Line Results with BEKINDA® for Acute Gastroenteritis Jun 14, 2017 Life Science
RepliCel Collaborates with University of British Columbia to Build World-Class Hair Follicle Cell Data Map Jun 14, 2017 Life Science
Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2017 Jun 5, 2017 Life Science
First Clinical Trial Of Embryonic Stem Cells Is Set To Treat Parkinson’s Disease And Blindness Jun 2, 2017 Life Science
Naturally Splendid Signs German Based Distributor and Ships Initial Purchase Order Jun 1, 2017 Life Science
Cancer Screening Tie-up: Hong Kong’s Cirina Merges With GRAIL, an Illumina Spin-Out Jun 1, 2017 Life Science
Resverlogix To Host Epigenetics Focused Symposium At The ERA-EDTA Congress in Madrid, Spain Jun 1, 2017 Life Science
Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone May 30, 2017 Life Science
Naturally Splendid announces LOI with Ambarii Corp to Distribute CBD Tablets in Japan and South Korea May 30, 2017 Life Science
